| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA206571
Max Phase: Preclinical
Molecular Formula: C31H40N4O6S
Molecular Weight: 596.75
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(=O)OC1OCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)c1ccc2c(c1)Nc1ccccc1S2
Standard InChI: InChI=1S/C31H40N4O6S/c1-17(2)14-24(34-28(37)20-10-11-27-23(16-20)32-21-8-6-7-9-26(21)42-27)30(39)35-25(15-18(3)4)29(38)33-22-12-13-40-31(22)41-19(5)36/h6-11,16-18,22,24-25,31-32H,12-15H2,1-5H3,(H,33,38)(H,34,37)(H,35,39)/t22-,24-,25-,31?/m0/s1
Standard InChI Key: BNGWXRGSXSJXMS-ZVUCNBDQSA-N
Associated Targets(Human)
CAPNS1 Tbio Calpain 1 (176 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 596.75 | Molecular Weight (Monoisotopic): 596.2669 | AlogP: 4.36 | #Rotatable Bonds: 11 |
| Polar Surface Area: 134.86 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
| #RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 12.09 | CX Basic pKa: | CX LogP: 4.12 | CX LogD: 4.12 |
| Aromatic Rings: 2 | Heavy Atoms: 42 | QED Weighted: 0.24 | Np Likeness Score: -0.14 |
References
| 1. Auvin S, Pignol B, Navet E, Troadec M, Carré D, Camara J, Bigg D, Chabrier PE.. (2006) Novel dual inhibitors of calpain and lipid peroxidation with enhanced cellular activity., 16 (6): [PMID:16380258] [10.1016/j.bmcl.2005.12.036] |
Source
Source(1):